Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Drug reduces the risk of child sexual abuse

A drug that lowers levels of the male hormone testosterone in the body reduces the risk of men with pedophilic disorder sexually abusing children, a study from Karolinska Institutet published today in the journal JAMA Psychiatry shows.About one in ten girls and one in twenty boys are sexually abused, primarily at the hands of men with pedophilic disorder. Despite law enforcement, technical and political initiatives, the rate of child sexual abuse continues to rise, above all that committed online. There is therefore a pressing need for effective and scientifically proven treatments for

EG7 Presents More Information About ‘83

Today EG7 presents more information about the own FPS-title '83. Enad Global 7 (EG7) releases more information about the title '83 today. '83 is a historic first-person shooter (FPS) set in an alternate world where the cold war has instead become hot. The title supports very large simultaneous player numbers (80+) and is developed by the EG7 studio Antimatter Games with support from Toadman Studios. '83 is scheduled to be released 2021-2022. The update mainly concerns the content of '83 and has been published on Antimatter Games’ social media accounts on Facebook, Twitter and Discord.

BONESUPPORT appoints Michael Roth as General Manager & Executive Vice President Commercial Operations North America

Lund, Sweden, 17.00 CET, 29 April 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries announces a change in its leadership team that will take place June 1, 2020. Michael Roth starts in the position as the company’s General Manager & Executive Vice President Commercial Operations North America. Michael has more than 20 years of experience within the orthopedic sector with both direct and distributor-based sales management. Michael has a solid leadership experience from both sales and marketing and from small as well as large companies, amongst them

TietoEVRY Corporation: Decisions of the Annual General Meeting on 29 April 2020

TietoEVRY Corporation         STOCK EXCHANGE RELEASE         29 April 2020, 6.00 p.m. EEST  TietoEVRY Corporation's Annual General Meeting approved the financial statements 2019 and discharged the company's officers from liability for the financial year 2019. The meeting also approved the Remuneration Policy for the company’s governing bodies and decided to amend the Articles of Association. Dividend payment The meeting decided to not distribute dividends by a decision of the Annual General Meeting. The meeting authorized the Board of Directors to decide at a later stage in its

Conveyance of YIT Corporation’s own shares under share-based incentive scheme

YIT Corporation     Stock exchange release       April 29, 2020 at 6:00 p.m.Conveyance of YIT Corporation’s own shares under share-based incentive scheme The Board of Directors of YIT Corporation has on April 29, 2020 decided on a directed share issue for the reward payment from the 2017 earnings period under YIT Group’s Incentive Scheme 2017–2022. In the share issue, a maximum of 291,575 YIT Corporation shares will be issued and conveyed without consideration to the key persons participating in the incentive scheme according to the terms and conditions of the incentive scheme. As the

Nordic Waterproofing A/S finally acquitted from accusations of competition law infringements

The Danish Competition and Consumer authority (Konkurrence- og Forbrugerstyrelsen) decides to finally close the investigation of the roofing felt market.  On 12 September 2018, The Danish Competition Appeals Tribunal annulled an earlier decision by the Danish Competition Council and referred the matter back to the Council for reconsideration.  By today's decision, the Competition and Consumer authority has finally closed the whole matter without finding any wrongdoing.At the Danish Competition Council's meeting today, it was decided to discontinue the investigation of the roofing felt

Fazer has renewed its baked goods: This spring, modern new products freshen the selection of sweet bakery products

Spring brings with it delicious and interesting flavours from Fazer Bakery. The new confectionery products freshening the market add flair to your celebrations, and the beautiful products also make for delightful gifts. Traditional snacks have new rivals in bakery products, the first soft, white bread for people with sensitive stomachs will hit the shops, and the street food trend will continue to prevail.The coming summer is a celebration of sweet buns, pastries and cakes Summer with its many special occasions is the golden age of bakery and confectionery products. At other times, sweet

#20-155 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#20-154 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Corrections to Metsä Board’s January–March 2020 interim report

Metsä Board Corporation Stock Exchange release 29 April 2020 at 5.45 p.m. EESTMetsä Board corrects its January–March 2020 interim report. In Key figures table on page 3, one row label is incorrect. The latter “Return on equity” should be “Return on capital employed”. In the cash flow statement on page 15, “Changes in non-current loans and in other financial items” correct figure is EUR -1.3 million (was EUR -50.3 million), “ Net cash flow from financing” correct figure is EUR -1.3 million (was EUR -50.3 million) and “Changes in cash and cash equivalents” correct figure is EUR 49.0

Transfer of EAB Group’s own shares

EAB Group Plc, Stock Exchange Release, 29 April 2020, 5:45 p.m. (EET) Transfer of EAB Group’s own shares On 29 April 2020, EAB Group Plc transferred without consideration a total of 3,958 own shares held by the company to current key employees of the company and 227 own shares to former key employees of the company. Altogether, a total of 4,185 shares were transferred. The transfer is related to the payment of deferred variable remuneration and is in accordance with the Company's remuneration scheme. The regulation requires that, to the extent that a reward scheme for so-called

Resolutions at the Annual General Meeting 2020

The Annual General Meeting of ASSA ABLOY AB was held on Wednesday 29 April 2020 in Stockholm, Sweden. Adoption of income statements and balance sheets and discharge from liability The Annual General Meeting adopted the parent company’s and the Group’s income statements and balance sheets. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2019. Dividend       The Annual General Meeting approved the dividend of SEK 2.00 per share proposed by the Board of Directors. The record date for the dividend was set to Monday 4 May 2020

BioStock: Aptahem's new CRD brings clinical experience to Phase I

Aptahem, whose primary drug candidate Apta-1 is being developed as an acute treatment for sepsis, recently announced that it is expanding its team with Suzanne Kilany as Clinical Research Director. The recruitment comes as the company prepares to move into clinical development with its main candidate. Kilany, who most recently comes from a position as Medical Scientific Adviser (MSA) at Astellas Pharma, is also a long-time board member of the Swedish Pharmaceutical Society’s clinical studies department. Here, she tells BioStock more about her new role at Aptahem.Read the full interview with

Securitas AB to publish the interim report on Thursday, May 7, 2020

Securitas AB will publish the interim report for January-March 2020 on Thursday, May 7, at app 1.00 p.m. (CET).1.00 p.m. (CET) Report releaseThe report will be sent as a press release from Cision (www.cision.se) and will automatically be published on www.securitas.com when released. 1.30 p.m. (CET) Presentation slides available For presentation slides, follow the link www.securitas.com/presentations   2.00 p.m. (CET) Telephone conference and audio castAnalysts and media are invited to participate in a telephone conference at 2.00 p.m. (CET) where Securitas President and CEO

Aker ASA: Invitation to Presentation of First-Quarter 2020 Results

Aker ASA will publish its first-quarter results for 2020 on Friday 8 May, at 07:00 CEST. The audio webcast and audio conference will start at 09:00 a.m. CEST the same morning. Please note that the results will be presented by audio webcast and audio conference only.Aker ASA first-quarter 2020 results presentation:Date: Friday 8 May 2020Time: 09:00 a.m. CESTFormat: Live audio webcast and audio conferenceLanguage: English To join the audio webcast:The webcast can be followed on Aker's website www.akerasa.com or https://channel.royalcast.com/webcast/hegnarmedia/20200508_6/  To

The Stockholm District Court approves RNB Retail and Brands subsidiaries´ requests for extending corporate reorganisation

The Stockholm District Court has today decided to grant extend of RNB Retail and Brands AB (publ) subsidiaries Departments & Stores Europe AB, Polarn O. Pyret AB and Brothers AB corporate reorganisations until June 23, 2020. “We are humble before the decisions to continue the corporate reorganisations. The decisions provide us with opportunity to continue to build strong businesses for the long term”, says Kristian Lustin, CEO, RNB Retail and Brands. For more details on the corporate reorganization please visit: www.rnb.se/en/Reorganisation/

Interim report Q1 2020

January - March · Net sales amounted to MSEK 793.6 (420.8). This corresponds to an increase of 89% for the period. The organic growth during the first quarter was 27%, currency impact -1% and 63% relates to the acquisition of Trimb in 2019 and the product portfolio acquired from Leo Pharma (see below). · EBIT amounted to MSEK 104.1 (87.4) corresponding to a 19% growth. · Adjusted EBITDA* amounted to MSEK 213.2 (153.0) corresponding to a 39% growth. This excluding non-recurring, costs related to the acquisition of the Leo Pharma portfolio totalling MSEK 3.9 (0.0). · The gross

Endomines Annual Report 2019 now published

Endomines AB, Stock Exchange Release 29 April 2020 at 16:00 CEST Endomines AB’s Annual Report in Swedish is now published on the Company’s website www.endomines.com The Finnish and English summary versions of the annual report will be published later. Contact personMarcus Ahlström, Deputy CEO and CFO, +358 50 544 68 14, marcus.ahlstrom@endomines.com The information was submitted for publication, through the agency of the contact person set out above, at 16:00 CEST on 29 April 2020.   About EndominesEndomines is a mining and exploration company with its primary focus on

Swedavia's Interim Report January-March 2020: Measures to face the dramatic traffic downturn

During the quarter as whole, 6.6 million passengers flew to or from Swedavia's airports, but during the second half of March, all air traffic nearly came to a standstill as a result of the Covid-19 pandemic. This is reflected in sales revenue, with Swedavia's net revenue declining during the period to 1,245 million Swedish kronor. Along with the priority work to help limit the spread of the disease and ensure people's health and safety, the quarter was dominated by measures to adapt operations to a minimum based on the drastic downturn in traffic. After the end of the period, on April 29 the

Genovis acquires all shares in QED Bioscience Inc., San Diego, CA, USA

Today Genovis acquired all shares in the privately held company QED Bioscience Inc. (QED), based in San Diego, California, USA. Genovis is paying about SEK 20 million in cash for the acquisition, including transaction costs. With a broadened product selection and a larger market, the company believes that after the acquisition it will be well-positioned to capture a larger share of the market for antibody labeling and associated contract research.As a result of the acquisition, Genovis will gain a well-established supplier of high-quality antibodies and a dedicated team with extensive

DNB’s Annual General Meeting will be held on 30 June 2020

The Board of Directors of DNB ASA has decided to hold the annual general meeting on 30 June 2020. Invitation to the annual general meeting will be sent in due time. Dividends for 2019 will not be considered at the annual general meeting, but at an extraordinary general meeting that will be held no later than December 2020. The new ex-dividend date will be the day after the extraordinary general meeting. On 2 April 2020, the Board of Directors of DNB ASA announced that the annual general meeting, planned to be held on 28 April 2020, would be postponed due to the extraordinary situation

Webinar: “Leadership during the Corona crisis” – experts from the University of Gothenburg highlighted human aspects

Around a hundred people participated April 16 when the University of Gothenburg, via GU Executive Education, hosted a webinar on “Leadership during the Corona crisis.” Three experts from three faculties at the university shared insights and advice on how leaders can best work against the backdrop of the Corona crisis. Much of the webinar focused on strengthening leadership capabilities and understanding the needs behind behaviors.The webinar started with a participant survey, which showed that the biggest dilemma right now for most people (49%) is "the difficulty to make decisions during

DNB Markets – Episurf Medical: Covid-19 to affect procedures

On 24 April Episurf Medical reported solid Q1 earnings, especially bearing in mind that EpiSealer procedures are typically elective and hence among the areas where healthcare organisations globally have lowered activity levels in the wake of Covid-19. This effect should be even more pronounced in Q2. Overall, we believe the company is moving in the right direction and its stable financial situation is a big benefit in the volatile times ahead due to the Covid-19 pandemic. We calculate a fair value of SEK1.4–4.1 (previously SEK1.6–4.3).Q1 affected by Covid-19 and impact set to increase in Q2.

Atria Plc announces appointments to the Board of Directors and to the Supervisory Board

Atria Plc, Company announcement, 29 April 2020 at 4.30 pm  Atria Plc announces appointments to the Board of Directors and to the Supervisory BoardIn its constitutive meeting following the Annual General Meeting, Atria Plc's Board of Directors elected Pasi Korhonen as Deputy Chairman of the Board of Directors. Seppo Paavola continues as Chairman of the Board of Directors. In its constitutive meeting following the Annual General Meeting, Atria Plc's Supervisory Board elected Jyrki Halonen as Chairman of the Supervisory Board. Juho Anttikoski continues as Deputy Chairman of the

There are no items matching the current filter
There are no more items matching the current filter
Back to top